Primary Site >> Biliary tract Cancer

Gene >> DAPK1

  • 2004
  • 2005
  • 2007
  • 2009
  • 2012
  • 2013
  • 2017
  • 2018
Ref: Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
PMID: 15447999
 Ref: Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
PMID: 15467712
Ref: Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
PMID: 15915369
 Ref: Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
PMID: 17690039
 Ref: Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
PMID: 18543280
 Ref: Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
PMID: 22230750
 Ref: P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer.
PMID: 23478949
 Ref: Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.
PMID: 28545228
 Ref: Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway.
PMID: 30136419